Novavax
NVAX
200 hedge funds and large institutions have $376M invested in Novavax in 2023 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 65 increasing their positions, 52 reducing their positions, and 51 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 52
1% more call options, than puts
Call options by funds: $69.1M | Put options by funds: $68.2M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less ownership
Funds ownership: 65.5% → 65.5% (-0%)
11% less funds holding
Funds holding: 225 → 200 (-25)
16% less capital invested
Capital invested by funds: $448M → $376M (-$72M)
45% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 51
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$40.4M |
| 2 |
Morgan Stanley
New York
|
+$30.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18.4M |
| 4 |
Coatue Management
New York
|
+$9.3M |
| 5 |
SCM
Shah Capital Management
Raleigh,
North Carolina
|
+$8.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$13.1M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$9.99M |
| 3 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$7.24M |
| 4 |
CF
Cantor Fitzgerald
New York
|
-$3.8M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.5M |
NVAX Hedge Fund Activity: Q4 2023 in Review
200 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q4 2023, worth a combined $376M — down 16% from $448M a quarter earlier.
Sellers outnumbered buyers: 51 funds closed out of NVAX and 28 opened new positions — a net loss of 23 holders — while 52 trimmed existing stakes and 65 added.
The largest buyer was State Street, adding an estimated $40.4M. The largest seller was Millennium Management, cutting an estimated $13.1M.
- 200 institutional investors held Novavax (NVAX) as of Q4 2023, down from 225 in Q3 2023.
- Funds reported $376M of Novavax stock for Q4 2023, down 16% quarter-over-quarter.
- 28 funds opened new Novavax positions in Q4 2023 and 51 closed out, a net change of -23 holders.
- The largest Novavax buyer in Q4 2023 was State Street, an estimated $40.4M added.
- The largest Novavax seller in Q4 2023 was Millennium Management, an estimated $13.1M sold.
Based on aggregated 13F filings for Q4 2023.